Octant Bio
Emeryville, US · 5 known investors
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Founders & leadership
SK
Sri KosuriCo-founder
Investors · 5
In the news
- Octant Bio Raises $175M Series B | SalesTools AIsalestools.io · 2025
- ReSync Bio: Drug Discovery Data Automation Company Raises Fundingpulse2.com · 2024
- Discovering New Drugs for Unsolved Diseases | Octant Biosaturdaystartups.beehiiv.com · 2023
- Octant Bio accepts $80m - Global Venturingglobalventuring.com · 2022
- Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approachforbes.com · 2020
- Octant Apprentice at Octant Biostartup.jobs